GENETIC-BASIS OF MULTIDRUG RESISTANCE OF TUMOR-CELLS

被引:142
|
作者
KANE, SE
PASTAN, I
GOTTESMAN, MM
机构
[1] NCI,CELL BIOL LAB,BETHESDA,MD 20892
[2] NCI,MOLEC BIOL LAB,BETHESDA,MD 20892
关键词
actinomycin D; ATP; Chemotherapy; colchicine; doxorubicin; drug transport; evolution; introns; MDR1; gene; P-glycoprotein; transmembrane domains; vinblastine; vincristine;
D O I
10.1007/BF00762963
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Multidrug resistance in animal cells is defined as the simultaneous resistance to a variety of compounds which appear to be structurally and mechanistically unrelated. One type of multidrug resistance is characterized by the decreased accumulation of hydrophobic natural product drugs, a phenotype which is mediated by an ATP-dependent integral membrane multidrug transporter termed P-glycoprotein or P170. The gene coding for P170 is called MDR. The nucleotide-binding domain of P-glycoprotein shares sequence homology with a family of bacterial permease ATP-binding components. In addition, P170 as a whole is structurally very similar to a number of prokaryotic and eukaryotic proteins believed to be involved in transport activities. This review summarizes our current knowledge of the molecular biology and clinical significance of MDR expression and P-glycoprotein transport activity, as well as some theories about the function of this protein in normal cells. © 1990 Plenum Publishing Corporation.
引用
收藏
页码:593 / 618
页数:26
相关论文
共 50 条
  • [21] Transfer of multidrug resistance among acute myeloid leukemia cells via extracellular vesicles and their microRNA cargo
    Bouvy, Celine
    Wannez, Adeline
    Laloy, Julie
    Chatelain, Christian
    Dogne, Jean-Michel
    LEUKEMIA RESEARCH, 2017, 62 : 70 - 76
  • [22] A NEW PROCEDURE FOR THE PREPARATION OF LIPOSOMAL DOXORUBICIN - BIOLOGICAL-ACTIVITY IN MULTIDRUG-RESISTANT TUMOR-CELLS
    THIERRY, AR
    RAHMAN, A
    DRITSCHILO, A
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1994, 35 (01) : 84 - 88
  • [23] Investigations on the cell metabolomics basis of multidrug resistance from tumor cells by ultra-performance liquid chromatography-mass spectrometry
    Zhang, Ruixing
    Zhuang, Xiaoyu
    Zong, Li
    Liu, Shu
    Liu, Zhiqiang
    Song, Fengrui
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2016, 408 (21) : 5843 - 5854
  • [24] GENETIC-ASPECTS OF MULTIDRUG RESISTANCE
    BIEDLER, JL
    CANCER, 1992, 70 (06) : 1799 - 1809
  • [25] Biochemical, Genetic, and Metabolic Adaptations of Tumor Cells That Express the Typical Multidrug-Resistance Phenotype. Reversion by New Therapies
    Loris G. Baggetto
    Journal of Bioenergetics and Biomembranes, 1997, 29 : 401 - 413
  • [26] Biochemical, genetic, and metabolic adaptations of tumor cells that express the typical multidrug-resistance phenotype. Reversion by new therapies
    Baggetto, LG
    JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 1997, 29 (04) : 401 - 413
  • [27] REVERSAL OF DOXORUBICIN-RESISTANCE IN SARCOMA-180 TUMOR-CELLS BY INHIBITION OF DIFFERENT RESISTANCE MECHANISMS
    EFFERTH, T
    VOLM, M
    CANCER LETTERS, 1993, 70 (03) : 197 - 202
  • [28] Susceptibility of multidrug resistance tumor cells to apoptosis induction by histone deacetylase inhibitors
    Castro-Galache, MD
    Ferragut, JA
    Barbera, VM
    Martín-Orozco, E
    Gonzalez-Ros, JM
    Garcia-Morales, P
    Saceda, M
    INTERNATIONAL JOURNAL OF CANCER, 2003, 104 (05) : 579 - 586
  • [29] Ascites Increases Expression/Function of Multidrug Resistance Proteins in Ovarian Cancer Cells
    Mo, Lihong
    Pospichalova, Vendula
    Huang, Zhiqing
    Murphy, Susan K.
    Payne, Sturgis
    Wang, Fang
    Kennedy, Margaret
    Cianciolo, George J.
    Bryja, Vitezslav
    Pizzo, Salvatore V.
    Bachelder, Robin E.
    PLOS ONE, 2015, 10 (07):
  • [30] Reversal effect of Tween-20 on multidrug resistance in tumor cells in vitro
    Yang, Shouhui
    Liu, JinJuan
    Chen, Yongqiang
    Jiang, Jihong
    BIOMEDICINE & PHARMACOTHERAPY, 2012, 66 (03) : 187 - 194